2019-11-01 Good Housekeeping

TALK TO YOUR ECZEMA SPECIALIST AND VISIT DUPIX(17&2025&$//ʘʖʒʒʘ'83,X(17ʘʖʒʒʘʑʖʕʘʒʗʑʔ 

ECZEMA: UNDER CONTROL.

SO ROLL UP THOSE SLEEVES.

JASON, REAL PATIENT.

Individual results may vary.

DUPIXENT is an innovation in the treatment of uncontrolled

PRGHUDWHWRVHYHUHHF]HPDDWRSLFGHUPDWLWLVIRUSHRSOHDQGXS

DUPIXENT is not a cream or steroid. It’s a biologic that continuously treats

eczema over time—even between flare-ups when skin looks clear. See and

feel the difference with:

Clearer skin • Significantly less itch

• (MBKHMHB@KSQH@KR@SȅȊVDDJRȇȋNE@CTKSR@MCȆȈNESDDMR@FDRȅȆ ȅȋ
  R@VBKD@QNQ@KLNRSBKD@QRJHMURȍ@MCȆMNSNMDUPIXENT.


• MCȇȌNE@CTKSR@MCȇȋNESDDMR@FDRȅȆ ȅȋG@CRHFMHEHB@MSKX
  KDRRHSBGURȅȅ@MCȉMNSNMDUPIXENT.

<280$<%((/,,%/()25$6/,77/($6$ʎ&23$< *Limitations apply. Visit DUPIXENT.com for full program terms.

INDICATION

DUPIXENT is a prescription medicine

TRDCSNSQD@SODNOKDȅȆXD@QRNE@FD

and older with moderate-to-severe

@SNOHBCDQL@SHSHRDBYDL@SG@SHR

not well controlled with prescription

SGDQ@OHDRTRDCNMSGDRJHMSNOHB@K

or who cannot use topical therapies.

DUPIXENT can be used w it h or w it hout

topical corticosteroids. It is not known

if DUPIXENT is safe and effective in

children with atopic dermatitis under

ȅȆXD@QRNE@FD

IMPORTANT SAFETY INFORMATION

Do not use if you are allergic to

dupilumab or to any of the ingredients

in DUPIXENT.

Before using DUPIXENT, tell your

healthcare provider about all your

medical conditions, including if you:

have eye problems; have a parasitic

GDKLHMSGHMEDBSHNM@QDS@JHMFNQ@K

SNOHB@KNQHMG@KDCBNQSHBNRSDQNHC

medicines. Do not stop taking your

corticosteroid medicines unless

instructed by your healthcare provider.

This may cause other symptoms that

were controlled by the corticosteroid

medicine to come back; are scheduled

to receive any vaccinations. You should

not receive a “live vaccine” if you are

treated with DUPIXENT; are pregnant

or pl an to become preg nant. It is not

known whether DUPIXENT will harm

your unborn baby; are breastfeeding

or pl an to breas t feed. It is not k nown

whether DUPIXENT passes into your

breast milk.

Tell your healthcare provider about

@KKSGDLDCHBHMDRXNTS@JDHMBKTCHMF

prescription and over-the-counter

LDCHBHMDRUHS@LHMR@MCGDQA@K

supplements. If you are taking asthma

LDCHBHMDRCNMNSBG@MFDNQRSNOXNTQ

asthma medicine without talking to

your healthcare provider.

DUPIXENT can cause serious side

effects, including:

• $OOHUJLFUHDFWLRQVK\SHUVHQVLWLYLW\ 
  including a severe reaction known
  as anaphylaxis. Stop using DUPIXENT

and tell your healthcare provider or

get emergency help right away if you

get any of the following symptoms:

AQD@SGHMFOQNAKDLREDUDQFDMDQ@K

HKKEDDKHMFRVNKKDMKXLOGMNCDR

RVDKKHMFNESGDE@BDLNTSG@MC

SNMFTDGHUDRHSBGHMFE@HMSHMF

CHYYHMDRREDDKHMFKHFGSGD@CDC

KNVAKNNCOQDRRTQDINHMSO@HM

or skin rash.

• Eye problems. Tell your healt hcare
  provider if you have any new or
  VNQRDMHMFDXDOQNAKDLRHMBKTCHMF
  eye pain or changes in vision.
  The most common side effects in
  patients with atopic dermatitis
  include HMIDBSHNMRHSDQD@BSHNMRDXD
  @MCDXDKHCHMEK@LL@SHNMHMBKTCHMF
  QDCMDRRRVDKKHMF@MCHSBGHMF@MCBNKC
  sores in your mouth or on your lips.
  Tell your healthcare provider if you
  have any side effect that bothers you or
  that does not go away. These are not all
  the possible side effects of DUPIXENT.
  Call your doctor for medical advice
  about side effects. You are encouraged

to report negative side effects of

prescription drugs to the FDA. Visit

VVV

EC@

FNULDCV@SBGNQB@KK

ȅȌȄȄ%# ȅȄȌȌ

Use DUPIXENT exactly as prescribed.

DUPIXENTHR@MHMIDBSHNMFHUDMTMCDQ

SGDRJHMRTABTS@MDNTRHMIDBSHNM

(E

your healthcare provider decides that

you or a caregiver can give DUPIXENT

HMIDBSHNMRXNTNQXNTQB@QDFHUDQRGNTKC

receive training on the right way to

OQDO@QD@MCHMIDBSDUPIXENT. Do not

SQXSNHMIDBSDUPIXENT until you have

been shown the right way by your

GD@KSGB@QDOQNUHCDQ

(MBGHKCQDMȅȆXD@QR

NE@FD@MCNKCDQHSHRQDBNLLDMCDC

that DUPIXENT be administered by or

under supervision of an adult.

Please see Brief Summary on next

page.

kʐʎʗ6DQRILDQG5HJHQHURQ

Pharmaceuticals, Inc.

KK1HFGSR1DRDQUDC

#4/

ȅȍ

Ȅȋ

ȄȊȉȄ